W Selby

Summary

Affiliation: University of Sydney
Country: Australia

Publications

  1. ncbi Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease
    Warwick Selby
    Royal Prince Alfred Hospital, Sydney, Australia
    Gastroenterology 132:2313-9. 2007
  2. ncbi Patient preferences between surgical and medical treatment in Crohn's disease
    Christopher M Byrne
    Surgical Outcomes Research Centre SOURCE, Sydney South West Area Health Service and University of Sydney, P O Box M157, Missenden Road, NSW, 2050, Sydney, Australia
    Dis Colon Rectum 50:586-97. 2007
  3. ncbi Pathogenesis and therapeutic aspects of Crohn's disease
    W Selby
    AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, NSW, Sydney, Australia
    Vet Microbiol 77:505-11. 2000
  4. ncbi The inability to visualize the ampulla of Vater is an inherent limitation of capsule endoscopy
    Warwick S Selby
    AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
    Eur J Gastroenterol Hepatol 23:101-3. 2011
  5. ncbi Cholecystectomy in patients with Crohn's ileitis
    Simon S B Chew
    Colorectal Unit, Prince of Wales Hospital, University of Sydney, Sydney, Australia
    Dis Colon Rectum 46:1484-8. 2003

Collaborators

  • Christopher M Byrne
  • Michael J Solomon
  • Simon S B Chew
  • Jane M Young
  • James D Harrison
  • Tru Q Ngo
  • Graham L Newstead
  • Philip R Douglas

Detail Information

Publications5

  1. ncbi Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease
    Warwick Selby
    Royal Prince Alfred Hospital, Sydney, Australia
    Gastroenterology 132:2313-9. 2007
    ..We report a prospective, parallel, placebo-controlled, double-blind, randomized trial of 2 years of clarithromycin, rifabutin, and clofazimine in active Crohn's disease, with a further year of follow-up...
  2. ncbi Patient preferences between surgical and medical treatment in Crohn's disease
    Christopher M Byrne
    Surgical Outcomes Research Centre SOURCE, Sydney South West Area Health Service and University of Sydney, P O Box M157, Missenden Road, NSW, 2050, Sydney, Australia
    Dis Colon Rectum 50:586-97. 2007
    ..The purpose of this study was to compare patients' preferences for surgical intervention in Crohn's disease with the preferences of surgeons and gastroenterologists...
  3. ncbi Pathogenesis and therapeutic aspects of Crohn's disease
    W Selby
    AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, NSW, Sydney, Australia
    Vet Microbiol 77:505-11. 2000
    ..The challenge remains to try and prevent resection of inflamed intestine and to improve the quality of life of those affected by this disorder...
  4. ncbi The inability to visualize the ampulla of Vater is an inherent limitation of capsule endoscopy
    Warwick S Selby
    AW Morrow Gastroenterology and Liver Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
    Eur J Gastroenterol Hepatol 23:101-3. 2011
    ..Lesions missed by capsule endoscopy (CE) have been reported and this may be partly because of the properties of the capsule. We aimed to compare the ability of Pillcam SB1, SB2, ESO1 and ESO2 to identify the ampulla of Vater (AoV)...
  5. ncbi Cholecystectomy in patients with Crohn's ileitis
    Simon S B Chew
    Colorectal Unit, Prince of Wales Hospital, University of Sydney, Sydney, Australia
    Dis Colon Rectum 46:1484-8. 2003
    ..In addition, the number of patients requiring cholecystectomy after ileal resection was low. Thus, synchronous prophylactic cholecystectomy during ileocolic resection for Crohn's ileitis is not justified...